Search clinical trials for: Infliximab Increased Dose

Total 7044 results

Biocad

Completed

Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

Russian Federation, Belarus
Asan Medical Center

Recruiting

TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease

Crohn Disease | Therapeutic Drug Monitoring | Infliximab | Perianal Fistula Due to Crohn's Disease | Magnetic Resonance Novel Index for Fistula Imaging in Crohn's Disease Score

Korea, Republic of
European Organisation for Research and Treatment...

Completed

Infliximab in Treating Patients With Myelodysplastic Syndrome

Myelodysplastic Syndromes

France, Belgium, Netherlands, Czech Republic, Italy, Germany
Chiesi Farmaceutici S.p.A.

Completed

Phase II Study to Evaluate the Cardiac Safety of 2 Doses of CHF5993 Both Combined With CHF1535 BID Versus CHF1535 BID in Patients With Moderate to Severe COPD (CARSAF)

Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Bulgaria, Germany, Hungary, Poland, Russian Federation, United Kingdom
Centocor, Inc.

Completed

A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis

Ulcerative Colitis

United States, Belgium, Canada, Netherlands, Denmark
Centocor, Inc.
Centocor BV

Completed

A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease

Crohn Disease
Rheumazentrum Ruhrgebiet
PPD; Centocor BV; Trial Coordination Center, 9713 GZ Groningen

Unknown

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

Belgium, Germany, Finland, France, Netherlands, United Kingdom
Chinook Therapeutics, Inc.

Active, not recruiting

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

IgA Nephropathy

Korea, Republic of, United States, United Kingdom
Suzhou Alphamab Co., Ltd.

Recruiting

KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia

Hemophilia

China
Pluristem Ltd.

Completed

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Intermittent Claudication | Peripheral Artery Disease

United States, Germany, Korea, Republic of, Israel
Epirus Biopharmaceuticals (Switzerland) GmbH

Unknown

BOW015 (Infliximab-EPIRUS) and Infliximab in Patients With Active Rheumatoid Arthritis: The UNIFORM Study

Rheumatoid Arthritis
Galapagos NV

Completed

First-in-Human Single and Multiple Dose of GLPG1837

Healthy

Belgium
University of Illinois at Urbana-Champaign

Completed

One Step at a Time: An Intervention to Reduce Sedentary Behavior Among Working Adults

Exercise | Sedentary Behavior | Adult | Middle Age

United States
University of Minnesota

Recruiting

Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients

Solid Organ Transplant

United States
Pfizer

Completed

Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)

Crohn's Disease | Ulcerative Colitis

Japan
Merck Sharp & Dohme LLC

Terminated

Treatment With Infliximab in a Medical Setting (Study P05587) (OPTIMIST)

Crohn's Disease
Vastra Gotaland Region

Completed

Predictors of Increased Physical Activity in Patients Receiving Physical Activity on Prescription

Physical Activity | Health Behavior | Primary Health Care | Metabolic Syndrome X

Sweden
Samsung Bioepis Co., Ltd.

Completed

A Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

Rheumatoid Arthritis

Bulgaria, Lithuania
Pfizer

Completed

A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).

Rheumatoid Arthritis

Jordan, Korea, Republic of, United States, Poland, Japan, Hungary, South Africa, Ukraine, Germany, Israel, Philippines, Serbia, Australia, Georgia, Czechia, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Guatemala, Lithuania, M... and more
Tufts Medical Center
National Institutes of Health (NIH)

Completed

A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).

COVID-19

United States
Centocor, Inc.
Centocor BV

Completed

A Long-term Safety Study of Infliximab (Remicade)

Arthritis, Rheumatoid | Psoriasis | Crohn Disease

United States, Canada, France, Germany, Poland, United Kingdom, Belgium, Spain, Argentina, Israel, Switzerland, Finland, Sweden, Netherlands, Austria, Hungary, Ireland, Norway, Denmark
Centocor, Inc.

Completed

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis

Psoriasis
Chinese University of Hong Kong

Recruiting

EUS-FNB With MOSE vs EUS-FNA With ROSE (MORE)

Pancreatic Neoplasms

Hong Kong
Xiaomin Zhang

Active, not recruiting

A Clinical Trial of Infliximab for Childhood Uveitis

Uveitis | Infliximab
Egla C. Rabinovich
Childhood Arthritis and Rheumatology Research Alliance

Completed

Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis

Chronic Uveitis

United States
Loyola University

Withdrawn

Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)

Toxic Epidermal Necrolysis
Peking Union Medical College Hospital
Changhai Hospital; West China Hospital; Shenzhen People's Hospital; First People... and other collaborators

Unknown

Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis (ULTRA)

Rheumatoid Arthritis | Ultrasonography | Infliximab

China
Center for Integrated Rehabilitation and Organ...
Centocor, Inc.

Completed

Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia

Cachexia | COPD

Netherlands
Mayo Clinic

Completed

A Study to Evaluate the Effects of Sharpened Romberg Testing (SRT) in Healthy Subjects

Hypocapnia | Balance; Distorted

United States
The Cleveland Clinic

Withdrawn

Food Energy Density in Eating Disorders

Nutritional Insufficiency
University of Athens

Terminated

Treatment of Refractory Diabetic Macular Edema With Infliximab

Diabetic Retinopathy | Diabetic Macular Edema | Visual Acuity

Greece
University of Cape Town
Bill and Melinda Gates Foundation

Completed

African Surgical OutcomeS-2 (ASOS-2) Trial (ASOS-2)

Surgery | Morality

South Africa
Cares, Kristen, M.D.

Recruiting

Infliximab Proactive Drug Monitoring in the Pediatric IBD Population

Inflammatory Bone Disease

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab (PRECISION)

Inflammatory Bowel Disease

Netherlands
James Chodosh, MD, MPH
Massachusetts Eye and Ear Infirmary; Fonds de recherche en ophtalmologie de...

Withdrawn

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Stevens-Johnson Syndrome | Mucous Membrane Pemphigoid | Toxic Epidermal Necrolysis (Lyell) Syndrome

United States, Canada
Centocor, Inc.

Completed

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease

Crohn Disease
Centocor, Inc.

Completed

A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease

Crohn Disease
Florida Academic Dermatology Centers

Completed

Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa (HS2006)

Hidradenitis Suppurativa

United States
University Hospital, Tours

Completed

Pharmaco Kinetic Variability of Infliximab in Rheumatoid Arthritis (FAKIR)

Rheumatoid Arthritis

France
Academisch Medisch Centrum - Universiteit van Amsterdam...
Netherlands Organisation for Scientific Research

Completed

Diet, Insulin Sensitivity And the Brain (DISAB)

Obesity | Diabetes Mellitus Type 2

Netherlands
Gu Jieruo

Completed

Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis

Spondylitis

China
Oregon Health and Science University
Centocor, Inc.

Completed

A Clinical Trial of Infliximab for Uveitis

Uveitis
Pfizer

Active, not recruiting

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)

Rheumatoid Arthritis

Japan
Northwestern University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Make Better Choices Study (MBC)

Heart Diseases | Cardiovascular Diseases

United States
Copenhagen University Hospital at Herlev
Lundbeck Foundation; Danish Medical Association; Aase and Ejnar Danielsens Foundation and other collaborators

Unknown

Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy

Crohn's Disease

Denmark
Damascus University

Completed

Effect of Laser Application in Pain Management Following the Use of Orthodontic Elastomeric Separators

Orthodontic Treatment

Syrian Arab Republic
Region Skane

Active, not recruiting

Influence of External Factors on Skeletal Growth in Youth

Fractures
Children's Hospital Medical Center, Cincinnati
The Gerber Foundation

Completed

Protein Supplementation in Infants With Brain Injury

Perinatal Stroke | White Matter Injury | Hypoxic-ischemic Encephalopathy

United States
University Hospital Freiburg

Unknown

Flow Proportional Pressure Support in Volunteers

Healthy

Germany
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Diet and Estrogen Metabolism in Postmenopausal Women

Breast Cancer

United States

Search clinical trials for: Infliximab Increased Dose

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations